Rebecca McShane

Rebecca (Noble) McShane is a seasoned professional with extensive experience in corporate strategy and market insights within the health and life sciences sector. Currently serving as Sr. Manager of Corporate Strategy at Beckman Coulter Diagnostics since April 2024, McShane previously held the position of Strategy & Market Insights Manager at Integrated DNA Technologies from June 2021 to April 2024. McShane's background includes a role as Senior Associate in Strategy and Business Development at PerkinElmer, where significant contributions to M&A pipeline development and executive-level presentations were made. Additionally, McShane worked at S2N Health, progressing from Analyst to Senior Analyst, providing strategic consulting to various stakeholders in the medical technology field. McShane possesses a Bachelor of Science in Biology from the University of Notre Dame and is currently pursuing an MBA at Babson F.W. Olin Graduate School of Business.